ABSTRACT
Despite the prevalence and significant impairment associated with attention deficit hyperactivity disorder-predominantly inattentive type (ADHD-I), treatment studies of this subtype are lacking, partially because the field has focused on the combined type of ADHD (ADHD-C), and also because the specification of ADHD-I as a distinct condition only occurred in 1994 (1). The critical lack of any treatment studies of ADHD-I was noted in the NIH Consensus Development Conference on ADHD (2) with the recommendation that more systematized treatment strategies be developed and evaluated for ADHD-I.
